NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
Back to search
Official data from USPTO
OSPOMYV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
06/17/2025
Trademark type
Word
Nice classes
5
Filing date
08/27/2024
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Incheon, KR
Examiner
TORPEY, KATHERINE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SAMSUNG BIOEPIS CO., LTD.
Representatives
Charles T. J. Weigell Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of hematologicalautoimmuneinflammatoryrespiratorytransplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparationspharmaceutical preparationsbiological formulationsbiological preparationsantibody formulations and protein formulations for immunoregulation and for treatment of immunologic disordersautoimmune diseasesinflammatory diseasesarthritiscancertumorcentral nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/06/2025
GNRT
NON-FINAL ACTION E-MAILED
03/06/2025
CNRT
NON-FINAL ACTION WRITTEN
03/06/2025
DOCK
ASSIGNED TO EXAMINER
03/04/2025
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/14/2024
ALIE
ASSIGNED TO LIE
11/14/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2024
NWAP
NEW APPLICATION ENTERED
08/27/2024
Continuous trademark protection
Get notified about every new filing that threatens OSPOMYV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.